Publications
2025
Exposure-response of ciclosporin and methotrexate in children and young people with severe atopic dermatitis: A secondary analysis of the TREatment of severe Atopic dermatitis Trial (TREAT).
Wan, M., Jones, A. P., Maskrey, D., Arenas-Hernandez, M., Rosala-Hallas, A., Beattie, P. E., . . . Flohr, C. (2025). Exposure-response of ciclosporin and methotrexate in children and young people with severe atopic dermatitis: A secondary analysis of the TREatment of severe Atopic dermatitis Trial (TREAT).. Clinical and experimental dermatology, llaf147. doi:10.1093/ced/llaf147
Methotrexate versus ciclosporin in the treatment of severe atopic eczema in children: an economic evaluation.
Sach, T. H., Chan, K. R., Jones, A. P., Rosala-Hallas, A., Spowart, C., Ashoor, F., . . . Flohr, C. (2025). Methotrexate versus ciclosporin in the treatment of severe atopic eczema in children: an economic evaluation.. The British journal of dermatology, 192(2), 349-350. doi:10.1093/bjd/ljae363
2024
Macrophage Therapy for Acute Liver Injury (MAIL): a study protocol for a phase 1 randomised, open-label, dose-escalation study to evaluate safety, tolerability and activity of allogeneic alternatively activated macrophages in patients with paracetamol-induced acute liver injury in the UK.
Humphries, C., Addison, M., Aithal, G., Boyd, J., Briody, L., Campbell, J. D. M., . . . Dear, J. W. (2024). Macrophage Therapy for Acute Liver Injury (MAIL): a study protocol for a phase 1 randomised, open-label, dose-escalation study to evaluate safety, tolerability and activity of allogeneic alternatively activated macrophages in patients with paracetamol-induced acute liver injury in the UK.. BMJ open, 14(12), e089417. doi:10.1136/bmjopen-2024-089417
The effects of ciclosporin and methotrexate on kidney function in the treatment of severe atopic dermatitis in children: results from the TREAT trial.
Bruce, G., Rosala-Hallas, A., Jones, A. P., Turner, C., Dalton, N., Hilger, E., . . . Flohr, C. (2024). The effects of ciclosporin and methotrexate on kidney function in the treatment of severe atopic dermatitis in children: results from the TREAT trial.. The British journal of dermatology, 191(5), 851-852. doi:10.1093/bjd/ljae276
HAP-FAST: a feasibility study incorporating qualitative, mechanistic and costing sub-studies alongside a randomised pilot trial comparing chest x-ray to low-dose CT scan and empirical antibiotics to antibiotics guided by the BIOFIRE® FILM ARRAY® pneumonia <i>plus</i> panel in adults with suspected non-ventilator-associated hospital-cquired pneumonia.
Shafiqa, N., Aston, S., Howard, A., Turtle, L., Abrams, S., Young, B., . . . Wootton, D. G. (2024). HAP-FAST: a feasibility study incorporating qualitative, mechanistic and costing sub-studies alongside a randomised pilot trial comparing chest x-ray to low-dose CT scan and empirical antibiotics to antibiotics guided by the BIOFIRE® FILM ARRAY® pneumonia <i>plus</i> panel in adults with suspected non-ventilator-associated hospital-cquired pneumonia.. BMJ open, 14(7), e088490. doi:10.1136/bmjopen-2024-088490
Stakeholders' perspectives on clinical trial acceptability and approach to consent within a limited timeframe: a mixed methods study.
Deja, E., Donohue, C., Semple, M. G., Woolfall, K., & BESS Investigators. (2024). Stakeholders' perspectives on clinical trial acceptability and approach to consent within a limited timeframe: a mixed methods study.. BMJ open, 14(1), e077023. doi:10.1136/bmjopen-2023-077023
2023
Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trial.
Flohr, C., Rosala-Hallas, A., Jones, A. P., Beattie, P., Baron, S., Browne, F., . . . TREAT Trial Investigators. (2023). Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trial.. The British journal of dermatology, 189(6), 674-684. doi:10.1093/bjd/ljad281
2022
Which outcomes should be used in future bronchiolitis trials? Developing a bronchiolitis core outcome set using a systematic review, Delphi survey and a consensus workshop
Rosala-Hallas, A., Jones, A. P., Williamson, P. R., Bedson, E., Compton, V., Fernandes, R. M., . . . McNamara, P. S. (2022). Which outcomes should be used in future bronchiolitis trials? Developing a bronchiolitis core outcome set using a systematic review, Delphi survey and a consensus workshop. BMJ Open, 12(3), e052943. doi:10.1136/bmjopen-2021-052943
Humidified and standard oxygen therapy in acute severe asthma in children (HUMOX): A pilot randomised controlled trial.
McNamara, P. S., Clayton, D., Burchett, C., Compton, V., Peak, M., Clark, J., & Jones, A. P. (2022). Humidified and standard oxygen therapy in acute severe asthma in children (HUMOX): A pilot randomised controlled trial.. PloS one, 17(2), e0263044. doi:10.1371/journal.pone.0263044
2021
Optimal outcome measures for a trial of not routinely measuring gastric residual volume in neonatal care: a mixed methods consensus process
Gale, C., Dorling, J., Arch, B., Woolfall, K., Deja, E., Roper, L., . . . Tume, L. (2021). Optimal outcome measures for a trial of not routinely measuring gastric residual volume in neonatal care: a mixed methods consensus process. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 106(3), F292-F297. doi:10.1136/archdischild-2020-319469
Prospective observational study of SARS-CoV-2 infection, transmission and immunity in a cohort of households in Liverpool City Region, UK (COVID-LIV): a study protocol
Setiabudi, W., Hungerford, D., Subramaniam, K., Vaselli, N. M., Shaw, V. E., Wilton, M., . . . French, N. (2021). Prospective observational study of SARS-CoV-2 infection, transmission and immunity in a cohort of households in Liverpool City Region, UK (COVID-LIV): a study protocol. BMJ Open, 11(3), e048317. doi:10.1136/bmjopen-2020-048317
Use of routinely collected data in a UK cohort of publicly funded randomised clinical trials
McKay, A. J., Jones, A. P., Gamble, C. L., Farmer, A. J., & Williamson, P. R. (2021). Use of routinely collected data in a UK cohort of publicly funded randomised clinical trials. F1000Research, 9, 323. doi:10.12688/f1000research.23316.3
P0080 / #320: IS A TRIAL OF NO ROUTINE GASTRIC RESIDUAL VOLUME MONITORING TO GUIDE ENTERAL FEEDING IS POSSIBLE IN UK PICUS AND NICUS?
Tume, L., Valla, F., Gale, C., Arch, B., Pathan, N., Latten, L., . . . Dorling, J. (2021). P0080 / #320: IS A TRIAL OF NO ROUTINE GASTRIC RESIDUAL VOLUME MONITORING TO GUIDE ENTERAL FEEDING IS POSSIBLE IN UK PICUS AND NICUS?. Pediatric Critical Care Medicine, 22(Supplement 1 3S), 73. doi:10.1097/01.pcc.0000738664.95044.d8
Determining Optimal Outcome Measures in a Trial Investigating No Routine Gastric Residual Volume Measurement in Critically Ill Children
Tume, L. N., Arch, B., Woolfall, K., Roper, L., Deja, E., Jones, A. P., . . . Dorling, J. (2020). Determining Optimal Outcome Measures in a Trial Investigating No Routine Gastric Residual Volume Measurement in Critically Ill Children. Journal of Parenteral and Enteral Nutrition. doi:10.1002/jpen.1817
Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and <i>Pseudomonas</i> <i>aeruginosa</i> infection: the TORPEDO-CF RCT
Hewer, S. C. L., Smyth, A. R., Brown, M., Jones, A. P., Hickey, H., Kenna, D., . . . Williamson, P. R. (2021). Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and <i>Pseudomonas</i> <i>aeruginosa</i> infection: the TORPEDO-CF RCT. HEALTH TECHNOLOGY ASSESSMENT, 25(65), 1-+. doi:10.3310/hta25650
2020
National survey of feasibility of NIV trials for management of children with bronchiolitis.
Rosala-Hallas, A., Jones, A. P., Bedson, E., Compton, V., Fernandes, R. M., Lacy, D., . . . McNamara, P. S. (2020). National survey of feasibility of NIV trials for management of children with bronchiolitis.. BMJ Paediatrics Open, 4(1), e000780. doi:10.1136/bmjpo-2020-000780
Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial
Hewer, S. C. L., Smyth, A. R., Brown, M., Jones, A. P., Hickey, H., Kenna, D., . . . Grp, T. O. R. P. E. D. O. -C. F. S. (2020). Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial. LANCET RESPIRATORY MEDICINE, 8(10), 975-986. doi:10.1016/S2213-2600(20)30331-3
Use of routinely collected data in a UK cohort of publicly funded randomised clinical trials [version 1]
McKay, A. J., Jones, A. P., Gamble, C. L., Farmer, A. J., & Williamson, P. R. (2020). Use of routinely collected data in a UK cohort of publicly funded randomised clinical trials [version 1]. F1000Research, 9. doi:10.12688/f1000research.23316.1
Routine gastric residual volume measurement to guide enteral feeding in mechanically ventilated infants and children: the GASTRIC feasibility study
Tume, L. N., Woolfall, K., Arch, B., Roper, L., Deja, E., Jones, A. P., . . . Dorling, J. (2020). Routine gastric residual volume measurement to guide enteral feeding in mechanically ventilated infants and children: the GASTRIC feasibility study. HEALTH TECHNOLOGY ASSESSMENT, 24(23), 1-+. doi:10.3310/hta24230
A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis (vol 10, 1796, 2020)
McWilliam, S. J., Rosala-Hallas, A., Jones, A. P., Shaw, V., Greenhalf, W., Jaki, T., . . . Pirmohamed, M. (2020). A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis (vol 10, 1796, 2020). SCIENTIFIC REPORTS, 10(1). doi:10.1038/s41598-020-61783-9
Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial
Ramanan, A. V., Dick, A. D., Guly, C., McKay, A., Jones, A. P., Hardwick, B., . . . APTITUDE Trial Management Group. (2020). Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial. The Lancet Rheumatology, 2(3), e135-e141. doi:10.1016/s2665-9913(20)30008-4
A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis.
McWilliam, S. J., Rosala-Hallas, A., Jones, A. P., Shaw, V., Greenhalf, W., Jaki, T., . . . Pirmohamed, M. (2020). A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis.. Scientific reports, 10(1). doi:10.1038/s41598-020-58790-1
Different corticosteroid induction regimens in children and young people with juvenile idiopathic arthritis: the SIRJIA mixed-methods feasibility study.
Jones, A. P., Clayton, D., Nkhoma, G., Sherratt, F. C., Peak, M., Stones, S. R., . . . Baildam, E. M. (2020). Different corticosteroid induction regimens in children and young people with juvenile idiopathic arthritis: the SIRJIA mixed-methods feasibility study.. Health Technology Assessment, 24(36), 1-152. doi:10.3310/hta24360
2019
P05 A national survey of clinical practice of corticosteroid use in newly diagnosed or flaring cases of juvenile idiopathic arthritis across the UK
Jones, A., Clayton, D., Nkhoma, G., Sherratt, F., Peak, M., Ramanan, A., . . . Baildam, E. (2019). P05 A national survey of clinical practice of corticosteroid use in newly diagnosed or flaring cases of juvenile idiopathic arthritis across the UK. Rheumatology, 58(Supplement_4). doi:10.1093/rheumatology/kez415.002
P07 Identifying the primary outcome measure and protocol components for a prospective feasibility study of corticosteroid regimens for CYP with JIA using consensus methods with young people, families and professionals
Stones, S. R., Bagley, H., Beresford, M. W., Jones, A., McErlane, F., Moitt, T., . . . Baildam, E. M. (2019). P07 Identifying the primary outcome measure and protocol components for a prospective feasibility study of corticosteroid regimens for CYP with JIA using consensus methods with young people, families and professionals. Rheumatology, 58(Supplement_4). doi:10.1093/rheumatology/kez415.003
Adalimumab in juvenile-idiopathic arthritis-associated uveitis (JIA-U): 5-year follow-up of the Bristol participants of the SYCAMORE trial.
Horton, S., Jones, A. P., Guly, C. M., Hardwick, B., Beresford, M. W., Lee, R. W. J., . . . Ramanan, A. V. (2019). Adalimumab in juvenile-idiopathic arthritis-associated uveitis (JIA-U): 5-year follow-up of the Bristol participants of the SYCAMORE trial.. American journal of ophthalmology. doi:10.1016/j.ajo.2019.06.007
A NATIONAL SURVEY OF CLINICAL PRACTICE OF CORTICOSTEROID USE IN NEWLY DIAGNOSED OR FLARING CASES OF JUVENILE IDIOPATHIC ARTHRITIS ACROSS THE UK
Baildam, E., Jones, A., Clayton, D., Nkoma, G., Peak, M., Ramanan, A., . . . Beresford, M. (2019). A NATIONAL SURVEY OF CLINICAL PRACTICE OF CORTICOSTEROID USE IN NEWLY DIAGNOSED OR FLARING CASES OF JUVENILE IDIOPATHIC ARTHRITIS ACROSS THE UK. In ANNALS OF THE RHEUMATIC DISEASES Vol. 78 (pp. 1934). doi:10.1136/annrheumdis-2019-eular.6751
Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO
Ramanan, A. V., Hampson, L. V., Lythgoe, H., Jones, A. P., Hardwick, B., Hind, H., . . . Beresford, M. W. (2019). Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO. PLOS ONE, 14(6). doi:10.1371/journal.pone.0215739
IDENTIFYING THE PRIMARY OUTCOME MEASURE AND PROTOCOL COMPONENTS FOR A PROSPECTIVE FEASIBILITY STUDY OF CORTICOSTEROID REGIMENS FOR CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS USING CONSENSUS METHODS WITH YOUNG PEOPLE, FAMILIES AND PROFESSIONALS
Stones, S., Bagley, H., Jones, A., Mcerlane, F., Moitt, T., Nkhoma, G., . . . Baildam, E. (2019). IDENTIFYING THE PRIMARY OUTCOME MEASURE AND PROTOCOL COMPONENTS FOR A PROSPECTIVE FEASIBILITY STUDY OF CORTICOSTEROID REGIMENS FOR CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS USING CONSENSUS METHODS WITH YOUNG PEOPLE, FAMILIES AND PROFESSIONALS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 78 (pp. 1934-1935). doi:10.1136/annrheumdis-2019-eular.1799
WS01-1 Effectiveness of IV compared to oral eradication therapy of Pseudomonas aeruginosa in cystic fibrosis: multicentre randomised controlled trial (TORPEDO-CF)
Langton Hewer, S. C., Smyth, A. R., Jones, A. P., Brown, M., Hickey, H., Williamson, P. R., . . . Ashby, D. (2019). WS01-1 Effectiveness of IV compared to oral eradication therapy of Pseudomonas aeruginosa in cystic fibrosis: multicentre randomised controlled trial (TORPEDO-CF). Journal of Cystic Fibrosis, 18, S1. doi:10.1016/s1569-1993(19)30117-1
Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT
Ramanan, A. V., Dick, A. D., Jones, A. P., Hughes, D. A., McKay, A., Rosala-Halas, A., . . . Grp, S. Y. C. A. M. O. R. E. S. (2019). Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT. HEALTH TECHNOLOGY ASSESSMENT, 23(15), 1-139. doi:10.3310/hta23150
Cost-Effectiveness Analysis of Adalimumab for the Treatment of Uveitis Associated with Juvenile Idiopathic Arthritis
Hughes, D. A., Culeddu, G., Plumpton, C. O., Wood, E., Dick, A. D., Jones, A. P., . . . Ramanan, A. V. (2019). Cost-Effectiveness Analysis of Adalimumab for the Treatment of Uveitis Associated with Juvenile Idiopathic Arthritis. Ophthalmology, 126(3), 415-424. doi:10.1016/j.ophtha.2018.09.043
2018
A randomized controlled trial protocol assessing the effectiveness, safety and cost-effectiveness of methotrexate vs. ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema Trial (TREAT)
Irvine, A. D., Jones, A. P., Beattie, P., Baron, S., Browne, F., Ashoor, F., . . . Flohr, C. (2018). A randomized controlled trial protocol assessing the effectiveness, safety and cost-effectiveness of methotrexate vs. ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema Trial (TREAT). BRITISH JOURNAL OF DERMATOLOGY, 179(6), 1297-1306. doi:10.1111/bjd.16717
Abstracts.
Irvine, A. D., Jones, A. P., Beattie, P., Baron, S., Browne, F., Ashoor, F., . . . TREAT Trial Investigators. (2018). Abstracts. . The British journal of dermatology, 179(6), e232-e262. doi:10.1111/bjd.17052
Interventions for helping people recognise early signs of recurrence in depression
Morriss, R. K., Bolton, C. A., McCarthy, J. P., Marshall, M., Williamson, P. R., & Jones, A. P. (2018). Interventions for helping people recognise early signs of recurrence in depression. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd004855.pub2
Humidified and standard oxygen therapy in acute severe asthma in children: a randomised controlled pilot trial (HUMOX)
Compton, V., Peak, M., Grice, J., Clark, J., Lee, L., Burchett, C., . . . McNamara, P. (2018). Humidified and standard oxygen therapy in acute severe asthma in children: a randomised controlled pilot trial (HUMOX). In EUROPEAN RESPIRATORY JOURNAL Vol. 52. doi:10.1183/13993003.congress-2018.OA341
A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial)
Ramanan, A. V., Dick, A. D., Jones, A. P., Guly, C., Hardwick, B., Hickey, H., . . . Beresford, M. W. (2018). A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial). BMC RHEUMATOLOGY, 2(1). doi:10.1186/s41927-018-0010-2
2017
63 TORPEDO-CF – completion of recruitment to trial of optimal regimen for eradication of new infection with Pseudomonas aeruginosa
Hewer, S. L., Hickey, H., Jones, A., Blundell, M., & Smyth, A. R. (2017). 63 TORPEDO-CF – completion of recruitment to trial of optimal regimen for eradication of new infection with Pseudomonas aeruginosa. Journal of Cystic Fibrosis, 16, S80. doi:10.1016/s1569-1993(17)30428-9
Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis
Ramanan, A. V., Dick, A. D., Jones, A. P., McKay, A., Williamson, P. R., Compeyrot-Lacassagne, S., . . . Grp, S. Y. C. A. M. O. R. E. S. (2017). Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis. New England Journal of Medicine, 376(17), 1637-1646. doi:10.1056/NEJMoa1614160
Hydroxyurea (hydroxycarbamide) for sickle cell disease.
Nevitt, S. J., Jones, A. P., & Howard, J. (2017). Hydroxyurea (hydroxycarbamide) for sickle cell disease.. The Cochrane database of systematic reviews, 4, CD002202. doi:10.1002/14651858.cd002202.pub2
2016
Assessing the feasibility of injectable growth-promoting therapy in Crohn's disease.
Altowati, M. A., Jones, A. P., Hickey, H., Williamson, P. R., Barakat, F. M., Plaatjies, N. C., . . . Sanderson, I. R. (2016). Assessing the feasibility of injectable growth-promoting therapy in Crohn's disease.. Pilot and feasibility studies, 2, 71. doi:10.1186/s40814-016-0112-9
ADALIMUMAB IN COMBINATION WITH METHOTREXATE FOR THE TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS ASSOCIATED UVEITIS: THE SYCAMORE TRIAL
Ramanan, A. V., Dick, A. D., Jones, A. P., McKay, A., Williamson, P. R., Compeyrot-Lacassagne, S., . . . Beresford, M. W. (2016). ADALIMUMAB IN COMBINATION WITH METHOTREXATE FOR THE TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS ASSOCIATED UVEITIS: THE SYCAMORE TRIAL. In ANNALS OF THE RHEUMATIC DISEASES Vol. 75 (pp. 264-265). doi:10.1136/annrheumdis-2016-eular.6053
2014
Risk-proportionate clinical trial monitoring: an example approach from a non-commercial trials unit
Smith, C. T., Williamson, P., Jones, A., Smyth, A., Hewer, S. L., & Gamble, C. (2014). Risk-proportionate clinical trial monitoring: an example approach from a non-commercial trials unit. TRIALS, 15. doi:10.1186/1745-6215-15-127
A Randomised Controlled Trial of the Clinical Effectiveness, Safety and Cost-Effectiveness of Adalimumab in Combination with Methotrexate for the Treatment of Juvenile Idiopathic Arthritis Associated Uveitis
Ramanan, A. V., Dick, A. D., McKay, A., Jones, A., Williamson, P., Compeyrot-Lacassagne, S., . . . Beresford, M. W. (2015). A Randomised Controlled Trial of the Clinical Effectiveness, Safety and Cost-Effectiveness of Adalimumab in Combination with Methotrexate for the Treatment of Juvenile Idiopathic Arthritis Associated Uveitis. ARTHRITIS & RHEUMATOLOGY, 67. Retrieved from https://www.webofscience.com/
A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial)
Ramanan, A. V., Dick, A. D., Benton, D., Compeyrot-Lacassagne, S., Dawoud, D., Hardwick, B., . . . The SYCAMORE Trial Management Group. (2014). A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial). Trials, 15. doi:10.1186/1745-6215-15-14
Risk-proportionate clinical trial monitoring: an example approach from a non-commercial trials unit.
Tudur Smith, C., Williamson, P., Jones, A., Smyth, A., Hewer, S. L., & Gamble, C. (2014). Risk-proportionate clinical trial monitoring: an example approach from a non-commercial trials unit.. Trials, 16(15), 127.
2013
The use of systematic reviews in the planning, design and conduct of randomised trials: a retrospective cohort of NIHR HTA funded trials
Jones, A. P., Conroy, E., Williamson, P. R., Clarke, M., & Gamble, C. (2013). The use of systematic reviews in the planning, design and conduct of randomised trials: a retrospective cohort of NIHR HTA funded trials. BMC MEDICAL RESEARCH METHODOLOGY, 13. doi:10.1186/1471-2288-13-50
The use of systematic reviews in the planning, design and conduct of randomised trials: a retrospective cohort of NIHR HTA funded trials
Jones, A., Conroy, E., Williamson, P., Clarke, M., & Gamble, C. (2013). The use of systematic reviews in the planning, design and conduct of randomised trials: a retrospective cohort of NIHR HTA funded trials. In Trials Vol. 14 (pp. O92). doi:10.1186/1745-6215-14-s1-o92
The use of systematic reviews in the planning,design and condut of randomised trials
Jones, A. P. (2013). The use of systematic reviews in the planning,design and condut of randomised trials [Public Performance].
2012
Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial
Gringras, P., Gamble, C., Jones, A. P., Wiggs, L., Williamson, P. R., Sutcliffe, A., . . . Appleton, R. (2012). Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial. BRITISH MEDICAL JOURNAL, 345. doi:10.1136/bmj.e6664
Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial
Gringras, P., Gamble, C., Jones, A. P., Wiggs, L., Williamson, P. R., Sutcliffe, A., . . . Appleton, R. (2012). Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial. BMJ, 345(nov05 1), e6664. doi:10.1136/bmj.e6664
The use of MElatonin in children with Neurodevelopmental Disorders and impaired Sleep: a randomised, double-blind, placebo-controlled, parallel study (MENDS)
Appleton, R. E., Jones, A. P., Gamble, C., Williamson, P. R., Wiggs, L., Montgomery, P., . . . Gringras, P. (2012). The use of MElatonin in children with Neurodevelopmental Disorders and impaired Sleep: a randomised, double-blind, placebo-controlled, parallel study (MENDS). HEALTH TECHNOLOGY ASSESSMENT, 16(40), 1-+. doi:10.3310/hta16400
The use of Melatonin in chidlren with Neurodevelopmental Disorders and impaired Sleep: a randomised double-blind, placebo-controlled, paralell study (MENDS)
Appleton, R. E., Jones, A. P., Gamble, C., Williamson, P. R., Wiggs, L., Montgomery, P., . . . Gringras, P. (2012). The use of Melatonin in chidlren with Neurodevelopmental Disorders and impaired Sleep: a randomised double-blind, placebo-controlled, paralell study (MENDS). HTA, 16(40).
2011
The use of the 5-year-olds' index: comparison between study models and intraoral photographs.
McAuliffe, N. J., Jones, A. P., Cumberbirch, V. C., & Russell, J. I. (2011). The use of the 5-year-olds' index: comparison between study models and intraoral photographs.. The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association, 48(5), 526-531. doi:10.1597/09-265
The use of Systematic reviews in the design of randomised controlled trials
Jones, A. P., Williamson, P. R., Clarke, M., & Gamble, C. (2011). The use of Systematic reviews in the design of randomised controlled trials. In MRC North West Hub for Trials Methodology Research 'Showcase Meeting' Vol. -. Liverpool: -.
The use of Systematic reviews in the design of randomised controlled trials
Jones, A. P., Williamson, P. R., Clarke, M., & Gamble, C. (2011). The use of Systematic reviews in the design of randomised controlled trials. In Clinical Trials Methodology conference Vol. -. -: MRC Network of HUBS for trials methodology Research.
The use of systematic reviews in the design of randomised trials
Jones, A. P., Gamble, C., Clarke, M., & Williamson, P. R. (2011). The use of systematic reviews in the design of randomised trials [Undetermined]. doi:10.1186/1745-6215-12-s1-a54
2010
Dornase alfa for cystic fibrosis.
Jones, A. P., & Wallis, C. (2010). Dornase alfa for cystic fibrosis.. The Cochrane database of systematic reviews, (3), CD001127. doi:10.1002/14651858.cd001127.pub2
Feasibility study to inform the design of a randomised controlled trial to eradicate <i>Pseudomonas aeruginosa</i> infection in individuals with Cystic Fibrosis
Hickey, H. R., Jones, A. P., Lenney, W., Williamson, P. R., & Smyth, R. L. (2010). Feasibility study to inform the design of a randomised controlled trial to eradicate <i>Pseudomonas aeruginosa</i> infection in individuals with Cystic Fibrosis. TRIALS, 11. doi:10.1186/1745-6215-11-11
2009
Erratum
Erratum (2009). Clinical Trials, 6(3), 288. doi:10.1177/1740774509339555
Does deworming improve growth and school performance in children?
Taylor-Robinson, D., Jones, A., & Garner, P. (2009). Does deworming improve growth and school performance in children?. PLoS neglected tropical diseases, 3(1), e358. doi:10.1371/journal.pntd.0000358
Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials
Jones, A. P., Riley, R. D., Williamson, P. R., & Whitehead, A. (2009). Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials. CLINICAL TRIALS, 6(1), 16-27. doi:10.1177/1740774508100984
2008
Can Western developmental screening tools be modified for use in a rural Malawian setting?
Gladstone, M. J., Lancaster, G. A., Jones, A. P., Maleta, K., Mtitimila, E., Ashorn, P., & Smyth, R. L. (2008). Can Western developmental screening tools be modified for use in a rural Malawian setting?. ARCHIVES OF DISEASE IN CHILDHOOD, 93(1), 23-29. doi:10.1136/adc.2006.095471
2007
Deworming drugs for treating soil-transmitted intestinal worms in children: effects on growth and school performance.
Taylor-Robinson, D. C., Jones, A. P., & Garner, P. (2007). Deworming drugs for treating soil-transmitted intestinal worms in children: effects on growth and school performance.. The Cochrane database of systematic reviews, (4), CD000371. doi:10.1002/14651858.cd000371.pub3
Non-invasive ventilation for cystic fibrosis.
Moran, F., Bradley, J. M., Jones, A. P., & Piper, A. J. (2007). Non-invasive ventilation for cystic fibrosis.. The Cochrane database of systematic reviews, (4), CD002769. doi:10.1002/14651858.cd002769.pub2
Interventions for helping people recognise early signs of recurrence in bipolar disorder
Morriss, R. K., Faizal, M. A., Jones, A. P., Williamson, P. R., Bolton, C., & McCarthy, J. P. (2007). Interventions for helping people recognise early signs of recurrence in bipolar disorder. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (1). doi:10.1002/14651858.CD004854.pub2
Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation
McLeod, C., Bagust, A., Boland, A., Dagenais, P., Dickson, R., Dundar, Y., . . . Walley, T. (2007). Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation. Unknown Journal, 1-158.
Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.
McLeod, C., Bagust, A., Boland, A., Dagenais, P., Dickson, R., Dundar, Y., . . . Walley, T. (2007). Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.. Health technology assessment (Winchester, England), 11(28), 1-iv. doi:10.3310/hta11280
Deworming drugs for treating soil-transmitted intestinal worms in children: effects on growth and school performance
Taylor-Robinson, D. C., Jones, A. P., & Garner, P. (2007). Deworming drugs for treating soil-transmitted intestinal worms in children: effects on growth and school performance. Cochrane Database of Sytematic reviews, (1).
Training patients to recognise and manage early warning signs delays recurrence of bipolar disorder
Morriss, R. K., Faizal, M. A., Jones, A. P., Williamson, P. R., Bolton, C., & McCarthy, J. P. (2007). Training patients to recognise and manage early warning signs delays recurrence of bipolar disorder. Evidence-Based Mental Health, 10, 110.
2005
A predominantly anti-inflammatory cytokine profile is associated with disease severity in meningococcal sepsis
Carrol, E. D., Thomson, A. P. J., Jones, A. P., Jeffers, G., & Hart, C. A. (2005). A predominantly anti-inflammatory cytokine profile is associated with disease severity in meningococcal sepsis. INTENSIVE CARE MEDICINE, 31(10), 1415-1419. doi:10.1007/s00134-005-2787-x
Nebulised hypertonic saline for cystic fibrosis.
Wark, P. A. B., McDonald, V., & Jones, A. P. (2005). Nebulised hypertonic saline for cystic fibrosis.. In Unknown Book (pp. CD001506). doi:10.1002/14651858.cd001506.pub2
High prevalence but low impact of data extraction and reporting errors were found in Cochrane systematic reviews
Jones, A. P., Remmington, T., Williamson, P. R., Ashby, D., & Smyth, R. L. (2005). High prevalence but low impact of data extraction and reporting errors were found in Cochrane systematic reviews. JOURNAL OF CLINICAL EPIDEMIOLOGY, 58(7), 741-742. doi:10.1016/j.jclinepi.2004.11.024
2004
Treatment of acute wheezing episodes in young children.
Smyth, R. L., & Jones, A. (2004). Treatment of acute wheezing episodes in young children.. The Journal of pediatrics, 145(2), 151-152. doi:10.1016/j.jpeds.2004.05.029
Interventions for helping people recognise early signs of recurrence in bipolar disorder
Morriss, R. M., Bolton, C. A., McCarthy, J. P., Marshall, M., Williamson, P. R., & Jones, A. P. (2004). Interventions for helping people recognise early signs of recurrence in bipolar disorder. In R. Morriss (Ed.). John Wiley & Sons, Ltd. doi:10.1002/14651858.cd004854
Interventions for helping people recognise early signs of recurrence in depression
Morriss, R., Bolton, C. A., McCarthy, J. P., Marshall, M., Williamson, P. R., & Jones, A. P. (2004). Interventions for helping people recognise early signs of recurrence in depression. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (3). doi:10.1002/14651858.CD004855
2003
Drug therapies for reducing gastric acidity in people with cystic fibrosis.
Ng, S. M., & Jones, A. P. (2003). Drug therapies for reducing gastric acidity in people with cystic fibrosis.. The Cochrane database of systematic reviews, (2), CD003424. doi:10.1002/14651858.cd003424
Recombinant human deoxyribonuclease for cystic fibrosis.
Jones, A. P., & Wallis, C. E. (2003). Recombinant human deoxyribonuclease for cystic fibrosis.. The Cochrane database of systematic reviews, (3), CD001127. doi:10.1002/14651858.cd001127
2001
Hydroxyurea for sickle cell disease.
Davies, S., & Olujohungbe, A. (2001). Hydroxyurea for sickle cell disease.. In Unknown Book (pp. CD002202). doi:10.1002/14651858.cd002202